Skip to main content
Peptide compounds discussed on this site are for educational and research purposes. Always consult a qualified specialist before use.
Reference KPV 5mg FOR RESEARCH
Preclinical Evidence Stage
Recovery Primary Domain
Subcutaneous injection or oral administration Routes Studied
30+ PubMed Citations
Recovery Peptide
Preclinical Only

KPV

Synthetic peptide studied in animal and cell models for anti-inflammatory activity and gastrointestinal mucosal protection

Last updated: March 1, 2026

Compound Data Sheet
Peer-reviewed References
Evidence Graded
Independent Editorial
Compound
KPV
Class
Recovery peptide
Summary
Synthetic peptide studied in animal and cell models for anti-inflammatory activity, gastrointestinal mucosal protection, selective anti-inflammatory action.
Mechanism
Mucosal Repair and Barrier Restoration
Research Status
Preclinical
Routes Studied
Subcutaneous injection or oral administration
Evidence Level
Preclinical-promising · Clinically unproven
[ QUICK.ANSWERS ]

What Should You Know About KPV?

What is KPV?
KPV is a synthetic peptide studied in animal and cell models for potent anti-inflammatory activity and gastrointestinal mucosal protection.
Is KPV clinically proven?
No. Human evidence remains limited and does not establish KPV as clinically proven.
What has KPV been studied for?
KPV has been studied in preclinical models of potent anti-inflammatory activity, gastrointestinal mucosal protection, selective anti-inflammatory action. These findings have not been confirmed in large-scale human trials.
Is KPV approved?
No. KPV is not an approved drug and remains a research compound.
[ COMPOUND.PROFILE ]

What Is KPV?

KPV is a naturally occurring tripeptide consisting of the amino acid sequence Lys-Pro-Val (lysine-proline-valine), corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). With a molecular weight of 342.43 g/mol and the molecular formula C16H30N4O4, KPV represents the minimal bioactive sequence responsible for the potent anti-inflammatory activity of the full alpha-MSH molecule. First identified through structure-activity relationship studies of alpha-MSH fragments, KPV was found to retain the anti-inflammatory properties of...

[ EVIDENCE.SUMMARY ]

Evidence Summary

Preclinical-promising · Clinically unproven

KPV has preliminary preclinical evidence only. Human clinical trial data is not available.

Evidence Breakdown

Domain Evidence Level
Anti-Inflammatory Activity Animal studies
Gastrointestinal Mucosal Protection Animal studies
Selective Anti-Inflammatory Action Animal studies
Antimicrobial and Wound Healing Properties Animal studies
Human clinical evidence Limited
Safety data Insufficient

Editorial Position

KPV is best understood as a preclinical research compound with promising biological signals but limited human validation. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.

Regulatory Status Snapshot

  • Not approved as a therapeutic drug by major regulators
  • Safety profile not established in large human populations

Need help interpreting this evidence for your situation?

Talk to a Specialist
[ STUDIED.FOR ]

What Has KPV Been Studied For?

Research areas where KPV has been investigated in published studies

  • Anti-Inflammatory Activity KPV has been studied in animal models of anti-inflammatory activity. These findings have not been confirmed in controlled human trials.
  • Gastrointestinal Mucosal Protection KPV has been studied in animal models of gastrointestinal mucosal protection. These findings have not been confirmed in controlled human trials.
  • Selective Anti-Inflammatory Action KPV has been studied in animal models of selective anti-inflammatory action. These findings have not been confirmed in controlled human trials.
  • Antimicrobial and Wound Healing Properties KPV has been studied in animal models of antimicrobial and wound healing properties. These findings have not been confirmed in controlled human trials.
[ MECHANISM ]

How Does KPV Work?

These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.

  1. 01 Cellular Uptake and IKK Complex Interaction
  2. 02 Intracellular signaling
  3. 03 JAK-STAT Pathway Modulation
  4. 04 Physiological outcome
NEXT STEP

Not sure if KPV is right for you?

A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about KPV.

Speak with a Specialist
[ COMMUNITY.FEEDBACK ]

Community Reports (Anecdotal)

Experiences shared here are self-reported and do not represent clinical evidence.

Rate KPV

Your privacy is protected. Share anonymously if you prefer.
Your Rating
[ ADMINISTRATION ]

How Is KPV Administered?

KPV is available via Subcutaneous injection or oral administration. Appropriate use and protocol should be determined by a qualified specialist.

[ REFERENCE.DATA ]

What Are the Specifications of KPV?

Format Lyophilized Powder
Amount 5mg per vial
Purity >99%
Purity Method HPLC (High-Performance Liquid Chromatography)
Sequence Lys-Pro-Val (C-terminal tripeptide of alpha-MSH, residues 11-13)
Molecular Weight 342.43 g/mol
Storage Store lyophilized powder at -20°C. Reconstituted solution at 2-8°C. Protect from light.
Appearance White to off-white lyophilized powder
[ EXPLORE ]

What Conditions Has KPV Been Linked To?

Have Questions About KPV?

Yes. Research has demonstrated that KPV retains biological activity when administered orally. The tripeptide is taken up by intestinal epithelial cells via the PepT1 oligopeptide transporter, enabling direct delivery to the gut mucosa.

Preclinical studies published in Inflammatory Bowel Diseases, the Journal of Biological Chemistry, and other peer-reviewed journals have demonstrated KPV's anti-inflammatory efficacy in models of colitis, skin inflammation, and wound healing.

Published studies on KPV can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.

Ready to discuss KPV with a specialist?

Get evidence-based guidance tailored to your health goals and medical context.

Book a Consultation Free initial consultation. No obligation.
EDITORIAL REVIEW

Reviewed by the Peptide Science Thailand Editorial Team.

Last reviewed: March 1, 2026

Share Your Experience

Not Medical Advice

The information provided on this website, including compound profiles, mechanism of action explanations, research summaries, dosage information, and educational content, is for informational and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment recommendations. No content on this website should be interpreted as a substitute for professional medical advice, diagnosis, or treatment.

Medical Supervision Essential

All peptide compounds discussed on this website should only be used under the supervision of a qualified specialist. A healthcare provider should evaluate individual health status, medical history, current medications, and specific health objectives before any peptide use. Self-administration of research peptides without medical supervision is strongly discouraged and may pose significant health risks.

Individual Variation

Individual responses to peptide compounds vary significantly based on genetics, age, body composition, existing health conditions, concurrent medications, and other biological factors. Dosage information provided on this website represents general research ranges and should not be used for self-dosing. A qualified specialist should determine the appropriate compound, dosage, administration route, cycle duration, and monitoring protocol based on individual health assessment.

Liability Limitation

Peptide Science Thailand assumes no liability for the misuse of information provided on this website. The content is provided for educational purposes only. Users are responsible for ensuring they work with qualified healthcare providers before using any peptide compounds discussed herein. Peptide Science Thailand is not responsible for adverse effects resulting from use without proper medical oversight.

Regulatory Status

Many peptides discussed here have not been evaluated or approved by the FDA for therapeutic use unless specifically noted (e.g., Tesamorelin, PT-141). The regulatory status of peptide compounds varies by jurisdiction. Some compounds discussed on this website are approved medications in other countries (e.g., Semax and Selank in Russia). This content is for informational and educational purposes only. Users are responsible for understanding and complying with all applicable laws and regulations in their jurisdiction.